Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
529 0 |
SM ISO690:2012 MASOUD, Dara, NOROC, Ecaterina. Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services. In: The Lancet Infectious Diseases, 2020, vol. 20, pp. 47-53. ISSN 1473-3099. DOI: https://doi.org/10.1016/S1473-3099(19)30524-9 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
The Lancet Infectious Diseases | |||||
Volumul 20 / 2020 / ISSN 1473-3099 /ISSNe 1474-4457 | |||||
|
|||||
DOI: https://doi.org/10.1016/S1473-3099(19)30524-9 | |||||
Pag. 47-53 | |||||
|
|||||
Rezumat | |||||
Globally, high rates (and in the WHO European region an increasing prevalence) of co-infection with tuberculosis and HIV and HIV and hepatitis C virus exist. In eastern European and central Asian countries, the tuberculosis, HIV, and viral hepatitis programmes, including diagnostic services, are separate vertical structures. In this Personal View, we consider underlying reasons for the poor integration for these diseases, particularly in the WHO European region, and how to address this with an initial focus on diagnostic services. In part, this low integration has reflected different diagnostic development histories, global funding sources, and sample types used for diagnosis (eg, typically sputum for tuberculosis and blood for HIV and hepatitis C). Cooperation between services improved as patients with tuberculosis needed routine testing for HIV and vice versa, but financial, infection control, and logistical barriers remain. Multidisease diagnostic platforms exist, but to be used optimally, appropriate staff training and sensible understanding of different laboratory and infection control risks needs rapid implementation. Technically these ideas are all feasible. Poor coordination between these vertical systems remains unhelpful. There is a need to increase political and operational integration of diagnostic and treatment services and bring them closer to patients. |
|||||
Cuvinte-cheie Asia Central, Coinfection, Diagnostic Services, Diagnostic Tests. Routine, Europe Eastern, health policy, hepatitis C, HIV infections, Humans, tuberculosis |
|||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <identifier identifierType='DOI'>10.1016/S1473-3099(19)30524-9</identifier> <creators> <creator> <creatorName>Masoud, D.</creatorName> <affiliation>Organizaţia Mondială a Sănătăţii, Danemarca</affiliation> </creator> <creator> <creatorName>Noroc, E.</creatorName> <affiliation>Spitalul Dermatologic şi Maladii Comunicabile, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='en'>Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2020</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1473-3099</relatedIdentifier> <subjects> <subject>Asia Central</subject> <subject>Coinfection</subject> <subject>Diagnostic Services</subject> <subject>Diagnostic Tests. Routine</subject> <subject>Europe Eastern</subject> <subject>health policy</subject> <subject>hepatitis C</subject> <subject>HIV infections</subject> <subject>Humans</subject> <subject>tuberculosis</subject> </subjects> <dates> <date dateType='Issued'>2020-02-01</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'><p>Globally, high rates (and in the WHO European region an increasing prevalence) of co-infection with tuberculosis and HIV and HIV and hepatitis C virus exist. In eastern European and central Asian countries, the tuberculosis, HIV, and viral hepatitis programmes, including diagnostic services, are separate vertical structures. In this Personal View, we consider underlying reasons for the poor integration for these diseases, particularly in the WHO European region, and how to address this with an initial focus on diagnostic services. In part, this low integration has reflected different diagnostic development histories, global funding sources, and sample types used for diagnosis (eg, typically sputum for tuberculosis and blood for HIV and hepatitis C). Cooperation between services improved as patients with tuberculosis needed routine testing for HIV and vice versa, but financial, infection control, and logistical barriers remain. Multidisease diagnostic platforms exist, but to be used optimally, appropriate staff training and sensible understanding of different laboratory and infection control risks needs rapid implementation. Technically these ideas are all feasible. Poor coordination between these vertical systems remains unhelpful. There is a need to increase political and operational integration of diagnostic and treatment services and bring them closer to patients. </p></description> </descriptions> <formats> <format>uri</format> </formats> </resource>